Nox Mobility | $2,341,030 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
10x Science (YC W26)
United States
- San Francisco, California
- 23/04/2026
- Seed
- $4,800,000
10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development.
AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis that cannot keep pace with discovery. Our AI-native platform automates it and serves as the unlock for this bottleneck, giving drug developers the confidence to advance the right candidates and stop the wrong ones early.
By applying modern AI to the development stage, specifically to protein characterization and quality assessment, we provide an end-to-end solution to dramatically speed up and scale up the preparation of candidates for the clinic.
Our team is composed of Stanford University researchers from a Nobel Laureate's lab with 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next generation of modern AI development in the life sciences.
- Industry Technology, Information and Internet
- Website https://www.10xscience.com/
- LinkedIn https://www.linkedin.com/company/10xscience/
Related People
David Stephen RobertsFounder
United States -
Stanford, California
Founder and CEO of 10x Science. Previously, I received my B.S. degrees in chemistry and mathematics in 2016 at UC San Diego, where I worked with Prof. Michael J. Sailor. I received my Ph.D. in chemistry in 2023 at the University of Wisconsin-Madison under the joint supervision of Prof. Ying Ge and Prof. Song Jin, where I was supported by an American Heart Association (AHA) predoctoral fellowship. My doctoral work focused on establishing new intact protein, “top-down”, mass spectrometry compatible methodologies and functionalized nanomaterials to address the major challenges of the human proteome dynamic range and the analysis of protein post-translational modifications. I then joined Prof. Carolyn Bertozzi's lab at Stanford University as a chemistry postdoctoral scholar and Damon Runyon Cancer Research Foundation Fellow, where I am developing chemical biology strategies to study the complex and fascinating world of glycobiology.
Omeza | $8,500,000 | (Apr 23, 2026)
Schematic | $6,500,000 | (Apr 23, 2026)
Crewline | $7,100,000 | (Apr 23, 2026)
Monk | $25,000,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)